Merck reports fiscal Q3 2025 results: revenue $17.28B, up 4% from a year earlier

Merck filed a Form 8-K with the SEC on Oct 30, 2025, 6:40 AM ET, reporting an event dated Oct 30, 2025. It covers Item 2.02 (Results of Operations and Financial Condition); Item 9.01 (Financial Statements and Exhibits). The results cover fiscal Q3 2025 (quarter ended Sep 30, 2025); figures below are from the company's XBRL financial data filed with the SEC.

• Revenue: $17.28B (+3.7% from $16.66B a year earlier)
• Net income: $5.79B (+83.2% from $3.16B a year earlier)
• Diluted EPS: $2.32 (+87.1% from $1.24 a year earlier)
• Form 8-K accepted by EDGAR Oct 30, 2025, 6:40 AM ET
• Accession number 0001104659-25-103974

SEC filing 8-K · accession 0001104659-25-103974 · sec.gov ↗